Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2002
05/15/2002EP1205490A1 Fusion protein comprising integrase (phiC31) and a signal peptide (NLS)
05/15/2002EP1205489A1 Polypeptide and nucleic acids encoding the same
05/15/2002EP1204868A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods
05/15/2002EP1204764A2 Methods of screening for angiogenesis modulators
05/15/2002EP1204760A2 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy
05/15/2002EP1204754A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
05/15/2002EP1204752A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof
05/15/2002EP1204751A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
05/15/2002EP1204750A1 Basb126 polypeptide and polynucleotide from moraxella catarhalis
05/15/2002EP1204749A2 Moraxella catarrhalis antigens basb122 and basb124
05/15/2002EP1204748A2 New g-protein coupled receptor and dna sequences thereof
05/15/2002EP1204747A1 G protein-coupled receptor expressed in brain
05/15/2002EP1204745A2 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations
05/15/2002EP1204744A1 Isolated peptide of the horny layer and use thereof
05/15/2002EP1204738A1 A method for decreasing the foam formation during cultivation of a microorganism
05/15/2002EP1204683A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
05/15/2002EP1204682A2 Compositions and methods for the treatment of tumors
05/15/2002EP1204681A2 Helical cytokine zalpha48
05/15/2002EP1204680A1 Molecular motor
05/15/2002EP1204679A1 Peptides containing n-substituted d-amino acids for preventing beta-strand association
05/15/2002EP1204678A1 Moraxella cattarrhalis basb114 antigens and uses thereof
05/15/2002EP1204674A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
05/15/2002EP1204673A2 Compositions and methods to enhance sensitivity of cancer cells to mitotic stress
05/15/2002EP1204424A1 Recombinant rsv virus expression systems and vaccines
05/15/2002EP1204422A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents
05/15/2002EP1204321A2 Super-active porcine growth hormone releasing hormone analog
05/15/2002EP1124723A4 Fuel nozzle dispenser using ultrasonic metering
05/15/2002EP0750509B1 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES
05/15/2002EP0610499B1 Proteoglycan(g 009) effective in enhancing antitumor immunity
05/15/2002CN1349543A Membrane disruptive peptides covalently oligomerized
05/15/2002CN1349410A Use of heparin-binding antagonists in the inhibition of bradykinin release
05/15/2002CN1348962A Rice pollen fertility controlling gene and its usage
05/15/2002CN1084598C Frozen confectionery products
05/14/2002US6388175 Nucleotide and amino acid sequence of albicidin detoxification enzyme; for transgenic plants with disease resistance
05/14/2002US6388173 Scarecrow promotor and uses thereof
05/14/2002US6388172 Phytochrome regulated transcription factor for control of higher plant development
05/14/2002US6388171 Host cell with stably incorporated expression cassette of promoter and specific nucleotide sequence; improved food grain quality
05/14/2002US6388169 Maize orthologues of bacterial RecA proteins
05/14/2002US6388132 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/14/2002US6388068 Nucleotide sequences of promoters; for efficient industrial production of exogenous polypeptides in plant xylem sap
05/14/2002US6388065 DNA for evaluating the progression potential of cervical lesions
05/14/2002US6388064 Human 2-19 protein homologue, z219a
05/14/2002US6388063 Diagnosis and treatment of SAD related disorders
05/14/2002US6388062 Protein which does not hertero-oligomerize with native p53; antitumor agents
05/14/2002US6388061 Includes ruthenium tris(bipyridyl) label bonded to the nitrogen base
05/14/2002US6388056 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host
05/14/2002US6388055 Mouse CC-CKR5 receptor polypeptide
05/14/2002US6388053 Mixing glucagon-like peptide-1 with a divalent metal cation, then incubating to form a complex; antidiabetic agents
05/14/2002US6388052 Amino acid sequence of nuclear factor of activated t lymphocytes, a transcription factor; immunomodulators
05/14/2002US6387888 Prostate cancer
05/14/2002US6387884 Modulate binding of leukocyte to endothelial cells; antiinflammatory agents
05/14/2002US6387879 Compounds that bind growth to hormone receptor
05/14/2002US6387877 Removal lipopolysaccharides from glycoproteins; antiinflammatory agents
05/14/2002US6387875 Method of use for murine leukaemia inhibitory factor-binding protein (mLBP)
05/14/2002US6387701 Method of identifying tumor antigens that elicit a T-cell response
05/14/2002US6387698 Polyclonal antiserum produced by immunzing animal with tumor rejection antigen precursor
05/14/2002US6387696 Human calcium channel compositions and methods
05/14/2002US6387688 Coriolus hirsutus host cell transformed with vector containing specific promoter; degradation of lignin in wood pulp
05/14/2002US6387686 Detecting nucleotide sequences which code cell surface protease; incubate target cells with viral display packages and detect signal from transformed cells
05/14/2002US6387684 Topoisomerase 1-mediated DNA delivery
05/14/2002US6387682 Amino acid sequence of polypeptide with cysteine protease activity; treatment of bone disorders such as osteoporosis; anticarcinogenic agents; antitumor agents; antimetastasis agents
05/14/2002US6387674 Has activity against betal amyloid 1-42 protein in beta sheet conformation; treatment of alzheimer's disease amyloidosis, atherosclerosis, and creutzfeld-jakob disease
05/14/2002US6387673 Anticarcinogenic agent composed of ligand for steroid/thyroid hormone superfamily of receptors, histone deacetylase inhibitor which interacts with receptor, and pharmaceutically acceptable carrier
05/14/2002US6387664 Fusion protein of defined amino acid sequence and which inhibits neuron adhesion to plastic; includes secreted protein acidic and rich in cysteine; treatment of nervous system disorders
05/14/2002US6387663 Fusion protein of collagen binding domain and angiogenesis modulating domain; treatment of cardiovascular disorders; antiischemic agents
05/14/2002US6387662 Constructing recombinant dna encoding core protein, envelope 1 protein, and envelope 2 protein; expressing dna in eukaryotic host cell and allowing assembly; then isolating non-infectious particle
05/14/2002US6387661 Nucleic acid molecules encoding human aminoacylase proteins
05/14/2002US6387658 PCNA-associated cell cycle proteins, compositions and methods of use
05/14/2002US6387657 Amino acid sequence of wnt-1-induced secreted protein; anticarcinogenic agents; antitumor agents; treatment of arteriosclerosis; diagnosis of related disorders
05/14/2002US6387656 Gene encoding MNR2 and uses thereof
05/14/2002US6387655 Excitatory amino acid receptor protein and related nucleic acid compounds
05/14/2002US6387645 Methods and materials relating to novel CD39-like polypeptides
05/14/2002US6387639 Ma family polypeptides and anti-Ma antibodies
05/14/2002US6387638 Heregulin variants
05/14/2002US6387627 Phagemid for antibody screening
05/14/2002US6387619 Telomerase compositions and methods
05/14/2002US6387616 Torsin, torsin genes, and methods of use
05/14/2002US6387615 Methods and materials for the diagnosis or prognosis of asthma
05/14/2002US6387377 Acellular antibordetella vaccine
05/14/2002US6387376 Recombinant vaccine containing feline herpes virus type 1 particularly for treating feline infectious peritonitis
05/14/2002US6387372 Polypeptides from mycrobacterium paratuberculosis
05/14/2002US6387371 Specifically binds to an extracellular domain of the her2 receptor in an amount effective to inhibit growth of cancer cells
05/14/2002CA2249180C Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides
05/14/2002CA2167090C Compositions and methods for stimulating megakaryocyte growth and differentiation
05/14/2002CA2144601C Recombinant type ii collagenase from clostridium histolyticum and its use for isolating cells and groups of cells
05/14/2002CA2104678C Protein-induced morphogenesis
05/14/2002CA2089742C Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
05/14/2002CA2086323C Functionally active selectin-derived peptides and ligand for gmp-140
05/14/2002CA2065409C Anticoagulant polypeptides
05/14/2002CA2032907C Hepatitis c assay
05/14/2002CA2032499C Polypeptide derivatives
05/14/2002CA2023899C Anti-sense oligonucleotide sequence, anti-rna messenger of tnf alpha, process for its preparation, use as medicament and pharmaceutical composition
05/10/2002WO2002037115A1 Detection of infectious agents using antigen mimics
05/10/2002WO2002037100A2 Novel applications of nickel nitrilotriacetic acid (ni-nta) resin: hemeprotein removal, recovery, and purification from biological samples
05/10/2002WO2002036832A2 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis
05/10/2002WO2002036816A2 Method of determining susceptibility to diseases
05/10/2002WO2002036807A2 Compositions and methods relating to breast specific genes and proteins
05/10/2002WO2002036806A2 Expression vectors able to elicit improved immune response and methods of using same
05/10/2002WO2002036804A2 Method for detecting hematopoietic stem cells
05/10/2002WO2002036793A2 Secreted protein associated with depression; composition and methods of use thereof